Bronx VA Medical Center

The Bronx, New York 10468

0 studies enrolling now · 13 studies all time

What they study most

Borderline Personality Disorder, COVID-19, Cardiovascular Diseases, Chronic Hepatitis C, Chronic Hepatitis C Virus Infection, Cognitive Impairment, Cognitive Impairment, Mild, Dementia, Frailty Syndrome, Hypercholesterolemia, Long COVID, Organ Dysfunction Syndrome, Multiple

Studies at this site

• Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults — Recruiting now
• COVID-19 Outcome Prediction Algorithm — Running, not enrolling
• Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. — Completed
• Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease — Completed
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 — Completed
• Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol — Completed
• Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe) — Completed
• Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive — Completed
• Study of CTS-1027 in Hepatitis C Patients — Completed
• Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia — Status unconfirmed
• Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia — Status unconfirmed
• DBT and Escitalopram in Borderline Personality Disorder — Status unconfirmed
• DBT in Borderline Personality Disorder — Status unconfirmed